Munich, Germany

Andreas Konard Buck

This inventor holds 1 USPTO granted patent. Top assignee: Technical University of Munich. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Konard Buck. Retrieved from https://idiyas.com/inventor/andreas-konard-buck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andreas Konard Buck: Innovator in Cyclopentapeptide Derivatives

Introduction

Andreas Konard Buck is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cyclopentapeptide derivatives. His research focuses on compounds that have potential applications in various therapeutic areas.

Latest Patents

Andreas Konard Buck holds one patent titled "Cyclopentapeptide derivatives and uses thereof." This invention relates to a compound characterized by a specific structure, which includes a combination of organic complexation agents and detectable labels. The patent outlines the potential uses of these compounds in medical applications, particularly in the delivery of active substances such as cytotoxic agents and proteins.

Career Highlights

Buck is affiliated with the Technische Universität München, where he engages in research and development activities. His work has contributed to advancements in the understanding and application of peptide derivatives in medicine.

Collaborations

He has collaborated with notable colleagues, including Oliver Demmer and Horst Kessler, to further enhance the impact of his research in the scientific community.

Conclusion

Andreas Konard Buck's innovative work in cyclopentapeptide derivatives exemplifies the importance of research in developing new therapeutic agents. His contributions continue to influence the field of pharmaceuticals and highlight the potential of peptide-based compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…